Загрузка видео...

Не удалось загрузить видео

На главную

Today we’re sharing a defining moment for Cellular Intelligence, for cell therapy, and hopefully one day for patients with Parkinson’s. We’re acquiring STEM-PD, a Phase 2-ready allogeneic cell therapy program for Parkinson’s from Novo Nordisk, who'll also be investing in CI.

MichaBreakstone's profile picture

Micha Breakstone

1,247 subscribers

19,556 просмотров • 3 месяцев назад •via X (Twitter)

LIVE

Anya Rossi• Live Now

Private livecam show

Комментарии: 0

Нет доступных комментариев

Здесь появятся комментарии из оригинального поста

Похожие видео

#BREAKINGNEWS: Bayer & BlueRock announce positive results in Phase I clinical study for a new investigational stem cell therapy for Parkinson’s disease (PD). An important milestone in our quest to meet unmet medical needs of those living with PD:
0:25

#BREAKINGNEWS: Bayer & BlueRock announce positive results in Phase I clinical study for a new investigational stem cell therapy for Parkinson’s disease (PD). An important milestone in our quest to meet unmet medical needs of those living with PD:

Bayer AG

30,762 просмотров • 3 лет назад

Pascal Touchon has been around cell therapy for a long time, and today he's the first to have an allo T-cell therapy approved. We talk about that, the EBV hypothesis for multiple sclerosis, and cell therapy for solid tumors
9:54

Pascal Touchon has been around cell therapy for a long time, and today he's the first to have an allo T-cell therapy approved. We talk about that, the EBV hypothesis for multiple sclerosis, and cell therapy for solid tumors

Brad Loncar

12,429 просмотров • 3 лет назад

Penn Medicine’s Carl June, MD, has won the 2024 Breakthrough Prize in Life Sciences for his work in CAR T cell therapy. T cell therapy marked a transformative moment in medicine & opened new possibilities for personalized therapies for patients worldwide. Congrats, Dr. June!
0:30

Penn Medicine’s Carl June, MD, has won the 2024 Breakthrough Prize in Life Sciences for his work in CAR T cell therapy. T cell therapy marked a transformative moment in medicine & opened new possibilities for personalized therapies for patients worldwide. Congrats, Dr. June!

Penn Medicine

48,237 просмотров • 2 лет назад

Looking for a new year's resolution with a difference for 2025? Joining the stem cell register means you will be on our lifesaving list and ready to help, if you are found to be a match for someone in need of a stem cell transplant. 💚
0:34

Looking for a new year's resolution with a difference for 2025? Joining the stem cell register means you will be on our lifesaving list and ready to help, if you are found to be a match for someone in need of a stem cell transplant. 💚

Anthony Nolan

33,726 просмотров • 1 год назад

.R3 Stem Cell here with the gang at R3 Stem Cell in Orlando...their newest location getting the rejuvenation therapy everyone can enjoy for maintaining good health and take the Creakiness out of your joints #BaldysBreakdowns
0:46

.R3 Stem Cell here with the gang at R3 Stem Cell in Orlando...their newest location getting the rejuvenation therapy everyone can enjoy for maintaining good health and take the Creakiness out of your joints #BaldysBreakdowns

Brian Baldinger

49,977 просмотров • 1 месяц назад

Breakthrough Update: Today, Vertex announced that they are beginning their Phase 3, or pivotal trial for VX-880, a stem cell-derived islet therapy. A pivotal trial gathers the data required for an FDA submission. This therapy is for people with type 1 diabetes (T1D) and hypoglycemia unawareness and severe hypoglycemic episodes. This is a HUGE first for the #T1D community as it is the first time a scalable cure for some people with T1D is entering this phase. Breakthrough T1D and the T1D Fund are incredibly proud to have supported this work in cell therapies—a top priority for our organization. We want to congratulate our partners at Vertex and thank all the patients who have participated in clinical trials. Your courage and commitment are inspiring. Learn more here:
1:29

Breakthrough Update: Today, Vertex announced that they are beginning their Phase 3, or pivotal trial for VX-880, a stem cell-derived islet therapy. A pivotal trial gathers the data required for an FDA submission. This therapy is for people with type 1 diabetes (T1D) and hypoglycemia unawareness and severe hypoglycemic episodes. This is a HUGE first for the #T1D community as it is the first time a scalable cure for some people with T1D is entering this phase. Breakthrough T1D and the T1D Fund are incredibly proud to have supported this work in cell therapies—a top priority for our organization. We want to congratulate our partners at Vertex and thank all the patients who have participated in clinical trials. Your courage and commitment are inspiring. Learn more here:

Breakthrough T1D

42,494 просмотров • 1 год назад

GREAT NEWS for the vaccine-injured in Japan… “This is life-changing…I have my life back…” Japan is HEALING vaccine-injured patients with DFPP + stem cell therapy. Dr. Mary Bowden has already sent 2 patients who got their lives back. THANK YOU 🙏🏻
1:24

GREAT NEWS for the vaccine-injured in Japan… “This is life-changing…I have my life back…” Japan is HEALING vaccine-injured patients with DFPP + stem cell therapy. Dr. Mary Bowden has already sent 2 patients who got their lives back. THANK YOU 🙏🏻

Liz Churchill

984,819 просмотров • 4 месяцев назад

🚨 BREAKING: Scientists in China grew brain cells in a lab, implanted them into Parkinson's patients, and saw real dopamine come back. Now the FDA has approved this therapy for Phase 1 in the US. This is XS-411. And it might be the most important stem cell story you haven't heard. 🧵 Thread 👇
0:20

🚨 BREAKING: Scientists in China grew brain cells in a lab, implanted them into Parkinson's patients, and saw real dopamine come back. Now the FDA has approved this therapy for Phase 1 in the US. This is XS-411. And it might be the most important stem cell story you haven't heard. 🧵 Thread 👇

Harshi Peiris, Ph.D.

53,392 просмотров • 4 месяцев назад

Chinese scientists have developed the world’s first iPSC-derived allogeneic cell therapy for drug-resistant epilepsy to win both China NMPA and US FDA clinical trial approvals. Unlike conventional drugs that mainly suppress symptoms, this therapy directly targets the damaged neurons at the root of seizures, repairs neural circuits, and aims for functional reconstruction. The procedure takes about an hour. Patients can usually leave hospital in 5 to 7 days. And the platform may later extend to Parkinson’s, Alzheimer’s, and other neurological disorders. That is not “Made in China,” but medicine rewritten in China. While some countries are still busy weaponizing supply chains, China is building the future of biomedicine.
1:50

Chinese scientists have developed the world’s first iPSC-derived allogeneic cell therapy for drug-resistant epilepsy to win both China NMPA and US FDA clinical trial approvals. Unlike conventional drugs that mainly suppress symptoms, this therapy directly targets the damaged neurons at the root of seizures, repairs neural circuits, and aims for functional reconstruction. The procedure takes about an hour. Patients can usually leave hospital in 5 to 7 days. And the platform may later extend to Parkinson’s, Alzheimer’s, and other neurological disorders. That is not “Made in China,” but medicine rewritten in China. While some countries are still busy weaponizing supply chains, China is building the future of biomedicine.

𝘊𝘰𝘳𝘳𝘪𝘯𝘦

12,921 просмотров • 4 месяцев назад

𝐒𝐅 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐖𝐞𝐞𝐤: Sana Bio's CEO Steve Harr describes the science behind the company's cell therapy program that aims to be a cure for type 1 diabetes. $SANA Full video:
4:40

𝐒𝐅 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐖𝐞𝐞𝐤: Sana Bio's CEO Steve Harr describes the science behind the company's cell therapy program that aims to be a cure for type 1 diabetes. $SANA Full video:

BiotechTV

19,210 просмотров • 6 месяцев назад

Johnny Lubin was one of the youngest patients in the clinical trial supporting today’s approval of the first CRISPR treatment in the US, one of two therapies approved today for sickle cell. He told us how the therapy has changed his life:
2:20

Johnny Lubin was one of the youngest patients in the clinical trial supporting today’s approval of the first CRISPR treatment in the US, one of two therapies approved today for sickle cell. He told us how the therapy has changed his life:

Meg Tirrell

26,914 просмотров • 2 лет назад

Team Route 66 Bikers Set Off from Chicago to Phoenix to Raise Parkinson’s Awareness CHICAGO — A group of cyclists known as “Team Route 66” began a cross-country journey on Monday morning, riding from Chicago to Phoenix to raise awareness and funds for Parkinson’s disease. The “Pedal for Parkinson’s” ride departed Navy Pier at around 10:30 a.m. The team includes about a dozen riders living with Parkinson’s and aims to reach Phoenix by May 24 for the World Parkinson Conference. The event brings together researchers, clinicians, nutritionists, patients, and caregivers focused on advancing understanding and treatment of the disease. VIA: ABC 7 Chicago
0:24

Team Route 66 Bikers Set Off from Chicago to Phoenix to Raise Parkinson’s Awareness CHICAGO — A group of cyclists known as “Team Route 66” began a cross-country journey on Monday morning, riding from Chicago to Phoenix to raise awareness and funds for Parkinson’s disease. The “Pedal for Parkinson’s” ride departed Navy Pier at around 10:30 a.m. The team includes about a dozen riders living with Parkinson’s and aims to reach Phoenix by May 24 for the World Parkinson Conference. The event brings together researchers, clinicians, nutritionists, patients, and caregivers focused on advancing understanding and treatment of the disease. VIA: ABC 7 Chicago

Breaking911

18,676 просмотров • 3 месяцев назад

Tamil Nadu govt inaugrates Hemato- Oncology and Bone Marrow transplant center in Egmore. Its 8 floors with 132 beds with a dedicated stem cell transplant unit. Equipped with ICU, isolation rooms and stem cell plasmapheresis. Blood cancers such as leukemias and Lymphomas will be treated here for free 🖤♥️
0:43

Tamil Nadu govt inaugrates Hemato- Oncology and Bone Marrow transplant center in Egmore. Its 8 floors with 132 beds with a dedicated stem cell transplant unit. Equipped with ICU, isolation rooms and stem cell plasmapheresis. Blood cancers such as leukemias and Lymphomas will be treated here for free 🖤♥️

Kavi

39,040 просмотров • 5 месяцев назад

We’re thrilled to announce CellWalk for iPhone and iPad! 📱✨ Journey to the atomic level and explore the molecular machines of a bacterial cell. We’re building the future of biology education—it’s interactive and immersive. #Apple #iPhone #iPad #scicomm #BiologyApp #STEM #EdTech #gamedev
0:40

We’re thrilled to announce CellWalk for iPhone and iPad! 📱✨ Journey to the atomic level and explore the molecular machines of a bacterial cell. We’re building the future of biology education—it’s interactive and immersive. #Apple #iPhone #iPad #scicomm #BiologyApp #STEM #EdTech #gamedev

Tim Davison ᯅ

51,412 просмотров • 2 лет назад

23-yo Daniel Cressy became one of fewer than 100 people in the world to receive gene therapy for sickle cell disease, and is now heading home with hope for a healthier life. This innovation is bringing new hope to families impacted by this disease! 🙌🏿
3:31

23-yo Daniel Cressy became one of fewer than 100 people in the world to receive gene therapy for sickle cell disease, and is now heading home with hope for a healthier life. This innovation is bringing new hope to families impacted by this disease! 🙌🏿

Ben Crump

109,823 просмотров • 3 месяцев назад

This World Parkinson’s Day, I want to extend my gratitude to organizations like The Micheal J. Fox Foundation. This foundation was a source of solace and invaluable resource for me and my family as we supported my father through Parkinson’s disease. I am inspired by the tireless effort of the foundation in finding breakthrough treatments, solutions and important support for patients in their everyday lives.
1:08

This World Parkinson’s Day, I want to extend my gratitude to organizations like The Micheal J. Fox Foundation. This foundation was a source of solace and invaluable resource for me and my family as we supported my father through Parkinson’s disease. I am inspired by the tireless effort of the foundation in finding breakthrough treatments, solutions and important support for patients in their everyday lives.

Cory Booker

14,898 просмотров • 4 месяцев назад

Today at #ASCO26, in collaboration with Moderna, we're proud to present five-year follow-up results from a Phase 2b study evaluating our investigational individualized neoantigen therapy for #melanoma. Learn more:
0:31

Today at #ASCO26, in collaboration with Moderna, we're proud to present five-year follow-up results from a Phase 2b study evaluating our investigational individualized neoantigen therapy for #melanoma. Learn more:

Merck

14,054 просмотров • 2 месяцев назад

Today, CEO Shankar Musunuri shares encouraging 12-month Phase 2 results for #OCU410 in GA, showing impact on lesion growth and visual function. A one-time gene therapy approach with potential to shift the landscape and address unmet needs. Read more:
1:39

Today, CEO Shankar Musunuri shares encouraging 12-month Phase 2 results for #OCU410 in GA, showing impact on lesion growth and visual function. A one-time gene therapy approach with potential to shift the landscape and address unmet needs. Read more:

Ocugen

11,533 просмотров • 4 месяцев назад

IN NEWS: Slingshot AI raises $93M for AI Therapy. We asked founders Neil Parikh and Daniel Cahn about how they're reinventing therapy. "We're inventing a whole new modality of therapy. Crises might happen at 2 AM, right? Your therapist isn't going to answer the phone." "We also don't want someone talking for 6 hours in a day." "Our AI does something unique; it will gently push you out, suggesting it's a good time to end for today."
1:40

IN NEWS: Slingshot AI raises $93M for AI Therapy. We asked founders Neil Parikh and Daniel Cahn about how they're reinventing therapy. "We're inventing a whole new modality of therapy. Crises might happen at 2 AM, right? Your therapist isn't going to answer the phone." "We also don't want someone talking for 6 hours in a day." "Our AI does something unique; it will gently push you out, suggesting it's a good time to end for today."

TBPN

15,315 просмотров • 1 год назад

23-Year-Old Daniel Cressy Became One Of Fewer Than 100 People In The World To Receive Gene Therapy For Sickle Cell Disease, And Is Now Returning Home With Hope For A Healthier Future. This Breakthrough Is Bringing New Hope To Families Affected By The Disease! 🙌🏿
3:31

23-Year-Old Daniel Cressy Became One Of Fewer Than 100 People In The World To Receive Gene Therapy For Sickle Cell Disease, And Is Now Returning Home With Hope For A Healthier Future. This Breakthrough Is Bringing New Hope To Families Affected By The Disease! 🙌🏿

Raphousetv (RHTV)

26,492 просмотров • 3 месяцев назад